Trials / Completed
CompletedNCT00035542
A Research Study to Determine the Safety and Efficacy of Glucovance Compared to Metformin and Glyburide in Children and Adolescents With Type 2 Diabetes.
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- —
- Sponsor
- Bristol-Myers Squibb · Industry
- Sex
- All
- Age
- 9 Years – 16 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this clinical research study is to see if Glucovance, a medication currently approved for use in adults with type 2 diabetes, can control type 2 diabetes safely and effectively in children 9 to 16 years of age.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Glucovance (metformin HCl/glyburide) | |
| DRUG | metformin HCl | |
| DRUG | glyburide |
Timeline
- Start date
- 2001-12-01
- Primary completion
- 2003-10-01
- Completion
- 2003-10-01
- First posted
- 2002-05-06
- Last updated
- 2011-04-15
Locations
50 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT00035542. Inclusion in this directory is not an endorsement.